FDA Gives Emergency Authorization of Hydroxychloroquine Use

The Food And Drug Administration (FDA) issued an emergency authorization Sunday for hydroxychloroquine, a drug already used to treat malaria and other ailments, which has shown anecdotal efficacy against coronavirus.

The use of the drug — often paired with azithromycin — has not yet been proven in clinical trials to be effective against the disease. However, given reported success in a growing number of small, non-randomized studies; as well as testimonials from doctors and patients about the use of the “off-label” drug regimen, doctors are said to be prescribing the treatment to patients who are severely ill. Anecdotally, many doctors are taking it prophylactically.

The Department of Health and Human Services (HHS) issued a statement on Sunday:

The U.S. Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA) to BARDA to allow hydroxychloroquine sulfate and chloroquine phosphate products donated to the Strategic National Stockpile (SNS) to be distributed and prescribed by doctors to hospitalized teen and adult patients with COVID-19, as appropriate, when a clinical trial is not available or feasible.

Watch: College Student Wants ‘Condemption’ of Rapists but Doesn’t Want ICE to Remove Them – She Also Can’t Figure Out What ICE Stands For

Dem Governor Begs Rich People Who Fled New York For Florida To Return And Foot Bill For ‘Generous Social Programs’

NYC’s First Lady Exposed Approving of Suicide Attack Propaganda, Plane Hijackers, and Outrageous Attacks on US Troops

Tensions and deadlocks over Trump’s US attorney picks hit fever pitch

Jewish voters feel ‘politically homeless’ as antisemitism rises on both sides

Pence: Trump upended ‘some aspects’ of GOP agenda but ‘hasn’t really changed the Republican Party’

Fairfax County ignored 2023 detainer against illegal immigrant now accused of murder, ICE says

Man found not guilty by reason of insanity in killing of pregnant Seattle woman, unborn child

Woman claims space rock smashed into house after Houston-area blast rattles residents

Trump gives Iran 48-hour ultimatum to reopen Strait of Hormuz or face strikes on power plants

Venezuelan migrant arrested after Loyola Chicago student fatally shot near campus

Dead passenger allegedly stored in heated galley for 13 hours on British Airways flight, ‘foul smell’ reported

Trump administration urges judge to dissolve injunction blocking Abrego Garcia’s deportation to Liberia

Florida woman seen on video allegedly attacking pregnant driver, elderly bystander and biting police officer

FIRST ON FOX: US Border Patrol nabs Mexican fugitives in California wanted for murder, child sex crimes

HHS also noted that it had “accepted 30 million doses of hydroxychloroquine sulfate donated by Sandoz, the Novartis generics and biosimilars division, and one million doses of chloroquine phosphate donated by Bayer Pharmaceuticals, for possible use in treating patients hospitalized with COVID-19 or for use in clinical trials.”

Earlier, the French government had approved similar drugs to treat the virus.

Amid concerns that the sudden interest in hydroxychloroquine could cause shortages, HHS noted: “Use of the donated medications is expected to help ease supply pressures for the drug, and the FDA is also working with manufacturers of chloroquine and hydroxychloroquine to increase production to ensure these drugs also remain available for patients dependent on them for treatment of malaria, lupus and rheumatoid arthritis.”